Latest News

Friday, July 29, 2016 | FDA Approval/Clearance, Alcon Laboratories, Transcend Medical

FDA Approves CyPass Micro-Stent Minimally Invasive Glaucoma Surgical Device

The FDA has approved Alcon's CyPass Micro-Stent system, the second minimally invasive glaucoma surgical device (MIGS) approved for use in combination with cataract surgery. The device helps to red…

Read the full story

Friday, July 29, 2016 | Product Releases, Imprimis Pharmaceuticals

Imprimis Launches New MaxRx Prescriber Portal

Imprimis Pharmaceuticals announced the availability of its new MaxRx Prescriber Portal, a software application that provides physicians with new order entry and management tools that have traditionall…

Read the full story

Friday, July 29, 2016 | Patents

Quark Pharmaceuticals Awarded Key Patent for QPI-1007 Ocular Neuroprotectant

Quark Pharmaceuticals announced that the United States Patent and Trademark Office (USPTO) has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic op…

Read the full story

Friday, July 29, 2016 | Medical Studies

Liquid Crystal Glasses Effective for Amblyopia

Liquid crystal (Amblyz) glasses that can alternate between opaque and transparent can be used as an alternative to intermittent patching for moderate unilateral amblyopia, according to a pilot study. …

Read the full story

Friday, July 29, 2016 | Product Releases, Alcon Laboratories

Alcon Launches DAILIES Total1 Multifocal, the First Water Gradient Contact Lenses Designed for People with Presbyopia

Alcon has introduced DAILIES Total1 Multifocal contact lenses designed for people with presbyopia. The water gradient lens is designed to provide distant, intermediate, and near vision and exceptional…

Read the full story

Friday, July 29, 2016 | Medical Studies

Vitreous Injection New Option for Postoperative Cataract Care

In an effort to overcome issues with noncompliance, a new study evaluated the efficacy of transzonular vitreous injection compared with standard topical therapy after cataract surgery and found outcom…

Read the full story

Thursday, July 28, 2016 | Clinical Trials, Dry Eye, Parion Sciences

Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease

Parion Sciences announced it has initiated a phase 2 clinical trial of P-321 ophthalmic dolution in patients with dry eye disease. P-321 is an inhibitor of the epithelial sodium channels (ENaC) on the…

Read the full story

Thursday, July 28, 2016 | Conferences

Vision Expo Education Positively Impacting Practices, Research Found

Eyecare providers can receive the high value education they seek to improve patient care and profitability while maximizing their time away from their practices by taking advantage of the 320+ hours o…

Read the full story

Thursday, July 28, 2016 | Medical Studies

Retinal Thinning a Marker for Cognitive Decline?

Thinning of the retinal nerve fiber layer (RNFL) is associated with poor cognitive function and may be a clinical marker for cognitive decline, a large study shows. The results indicate that RNFL thin…

Read the full story

Wednesday, July 27, 2016 | Acquisitions/Mergers, Allergan

Teva Purchase of Allergan Generics Business Gets OK with Conditions

Teva Pharmaceutical Industries won US antitrust approval to purchase Allergan's generics business after agreeing to divest more than 75 generic drugs to rival firms, the Federal Trade Commission s…

Read the full story

Wednesday, July 27, 2016 | Acquisitions/Mergers, Allergan

FTC Requires Teva to Divest Over 75 Generic Drugs to Settle Competition Concerns Related to its Acquisition of Allergan’s Generic Business

Teva Pharmaceutical Industries has agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan's generi…

Read the full story

Wednesday, July 27, 2016 | Product Releases, CenterVue

CenterVue Launches Fixation Training Module to Help Low Vision Patients with Central Vision Loss

CenterVue announced it has received FDA 510(k) clearance for fixation training for its MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio feedback. The des…

Read the full story

Wednesday, July 27, 2016 | Product Releases, Modernizing Medicine

Modernizing Medicine Releases New Software Suite for Medical Specialties

Modernizing Medicine revealed the latest edition of its software, modmed 5.0, a comprehensive specialty-specific suite developed to address the diverse and growing needs of medical practices. The upda…

Read the full story

Wednesday, July 27, 2016 | Management/Leadership, AcuFocus

AcuFocus Appoints Alan Waterhouse President and Chief Operating Officer; William Link, PhD, to Become Chairman of the Board

AcuFocus announced the appointment of Alan Waterhouse as the company’s President and Chief Operating Officer, and William Link, PhD, as Chairman of the Board. Mr. Waterhouse will also take a sea…

Read the full story

Wednesday, July 27, 2016 | Management/Leadership, Carl Zeiss Meditec

James Mazzo Named Global President of Ophthalmology at Carl Zeiss Meditec

James V. Mazzo will join Carl Zeiss Meditec as Global President of Ophthalmology and will be responsible for the new Strategic Business Unit Ophthalmology as well as Carl Zeiss Meditec's US Sales …

Read the full story
Load More